21 November 2022 - - UK-based healthcare and pharmaceutical company SpectrumX has appointed Sheena Powell as regional account manager, UK South West, to its sales team, the company said.

The move comes as CEO Damien Hancox and the SpectrumX team brings its novel Spectricept product line of high-level, skin-safe disinfectants to market and the company's plans to expand business further into the UK, Ireland, and Europe.

Powell has been brought on board to drive commercial activity and generate growth in the UK's South West, a market region spanning from the West Midlands down into Dorset, Cornwall, and Hampshire, and also includes South Wales.

She is responsible for leading go-to-market and sales strategies in the region, driving product awareness, creating new business opportunities and providing greater support for UK clients.
Powell brings a wealth of experience in the healthcare sector to her new role.

She holds a master's degree in infection control from University of the Highlands and Islands, Scotland.

She has held progressively senior roles in marketing and sales roles for healthcare and medical supplies companies.

Most recently, she was national sales manager for Innovation Rehab, a leading UK manufacturer of orthopaedic and podiatry appliances, and southern regional sales manager for Frontier Medical Group, a leading UK manufacturer and supplier of infection prevention and control products.

She also practiced as a registered general nurse at Guy's and St Thomas' NHS Hospital Foundation Trust in London, which gives her deep knowledge of infection prevention measures and experience in the healthcare facilities setting.

Spectricept products, currently consisting of an alcohol-free hand sanitiser and a body wash, are pH-neutral, high-level disinfectants.

The active ingredient is the company's patent-pending, stabilised form of hypochlorous acid, which lab tests indicate is 99.99% effective against bacteria, viruses, fungi, and yeasts on skin.

SpectrumX is a UK-based healthcare and pharmaceuticals company focused on bringing to market an innovative respiratory infection therapy and the roll-out of the most powerful hand sanitiser in the world to the NHS and other healthcare clients.

Both products utilise unique, patent-pending HOCl formulations. HOCl is naturally occurring in human white blood cells and is a key contributor in the immune response to infection.

HOCl also has direct killing activity against bacteria, viruses and fungi. It is well-tolerated in humans while also being the most effective known disinfectant when used on surfaces.